Managing intellectual property and technology transfer Contents

Witnesses

The following witnesses gave evidence. Transcripts can be viewed on the inquiry publications page of the Committee’s website.

Wednesday 2 November 2016

Dr Tony Raven, Chief Executive, Cambridge Enterprise, Nick Sturge, Director, Engine Shed, University of Bristol, and Dr Claire Brady, Head of Technology Transfer, Edinburgh Research and Innovation, The University of Edinburgh

Q1–67

Dr Phil Clare, Chair, Advocacy Committee, PraxisUnico, Dr Rosa Fernández, Research Director, National Centre for Universities and Business, and Dr Toby Basey-Fisher, Chief Executive, Eva Diagnostics

Q68–110

Tuesday 22 November 2016

Dr Will West, Executive Chairman, CellCentric and Member, BioIndustry Association Board, Felicity Burch, Head of Innovation and Digital, CBI, and Richard North, Head of IP Protection Licensing and Control, Rolls-Royce

Q111–154

Anne Glover, Co-founder and Chief Executive, Amadeus Capital Partners Ltd, Chris Mairs CBE FREng, Venture Partner, Entrepreneur First, and Mike Conroy, Executive Director, Corporate and Commercial Banking, British Bankers’ Association

Q155–198

Wednesday 14 December 2016

Mark Anderson, The Law Society IP Law Committee, and Dr Daniel Nelki, Science to Health Lead, Wellcome Trust

Q199–241

Professor Dame Ann Dowling, President, Royal Academy of Engineering, and Professor Trevor McMillan, Vice-Chancellor, Keele University

Q242–272

Wednesday 11 January 2017

Jo Johnson MP, Minister of State for Universities, Science, Research and Innovation, Department for Business, Energy and Industrial Strategy, Jenny Dibden, Director of Science and Research, Department for Business, Energy and Industrial Strategy, and Sean Dennehey, Acting Chief Executive Officer, Intellectual Property Office

Q273–323





10 March 2017